Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 36INDUSTRY 16NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 134Urinary Bladder Neoplasms 47Kidney Neoplasms 38Carcinoma, Renal Cell 30Wilms Tumor 29Testicular Neoplasms 21Urethral Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Breast Neoplasms 14Neuroblastoma 12Sarcoma 11Teratoma 10Carcinoma, Non-Small-Cell Lung 9Testicular Germ Cell Tumor 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Germ Cell Cancer 8Lung Neoplasms 8Endodermal Sinus Tumor 8Colorectal Neoplasms 7Burkitt Lymphoma 7Seminoma 6Osteosarcoma 6Neoplasms 6Colonic Neoplasms 6Carcinoma, Ovarian Epithelial 6Teratoma, Testicular 5Recurrence 5Pain 5Head and Neck Neoplasms 5

Interventions

pembrolizumab 1lenvatinib 1cabozantinib 1Specimen Handling 1Pluvicto 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Clear-cell metastatic renal cell carcinoma × Genitourinary × Clear all
NCT06783348 2026-06-04

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT04510597 2025-09-09

PROBE

SWOG Cancer Research Network

Phase 3 Recruiting
364 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡